← Browse by Condition
Medical Condition
obstructive hypertrophic cardiomyopathy
Total Trials
3
Recruiting Now
3
Trial Phases
Various
NCT06023186
Recruiting
Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
Enrollment
20 pts
Location
United States
Sponsor
Michael Ayers
NCT06146660
Recruiting
A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Enrollment
600 pts
Location
South Korea
Sponsor
Bristol-Myers Squibb
NCT06551129
Recruiting
Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
Enrollment
118 pts
Location
United States
Sponsor
Bristol-Myers Squibb